View details
PJSC «Kraspharma»: we promote our own developments, exploring new therapeutic areas
PJSC «Kraspharma» is a leader in the production of hospital medications
PJSC «Kraspharma» is a domestic pharmaceutical company with over 65 years
of experience in manufacturing
pharmaceutical products that meet all national and international quality standards
WE MANUFACTURE PHARMACEUTICAL PRODUCTS,
HAVING EXCLUSIVELY
HIGH CLINICAL VALUE
and in demand in the provision of qualified medical care for both adults and children
PJSC «Kraspharma» is a strategic enterprise: strategic both in terms of its economic component and its social significance. It is also key to the implementation of the strategy for ensuring and maintaining the pharmaceutical security of the Russian Federation. We take on a very high level of commitment and responsibility. The main principle of the company's operations is: "Our medicines save lives
We strive to meet the healthcare needs for modern and effective medicines. We follow the industry's development strategy and bring pharmaceutical products to the market for the treatment and prevention of socially significant diseases.
Antibiotics
Powders, lyophilizates, and liquid formulations
The antimicrobial drugs produced by PJSC «Kraspharma»
Offer undeniable advantages and are distinguished by their quality, effectiveness, and safety.
Antituberculosis Drugs
Powders, Lyophilizates, and Solutions
Focused on Effective Treatment of Severe Forms of Tuberculosis
Including cases caused by multidrug-resistant pathogens
Plasma Substitutes
Sterile Solutions
Essential Plasma Substitutes
Indispensable for providing quality medical care in hospital settings
Treatment of Peptic Ulcer Disease and GERD
Powders and Lyophilizates
Medications for Effective Treatment of Acid-Dependent Conditions
Treatment and prevention of gastrointestinal bleeding and complications
Latest news
PJSC Kraspharma has launched the antifungal medication Konmik infusion solution on the market.
25.02.2025
Konmik (INN: Flucomabol) is a synthetic antifungal agent from the triazole class. It is well known that infections caused by pathogenic fungi pose a significant challenge in intensive care and emergency departments, as well as in the practice of oncologists, immunologists, and HIV specialists.
View details
Polymyxins—particularly colistimethate—remain the only effective treatment option for life-threatening infections caused by Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae (e.g., Klebsiella spp.).
View details
A new addition to PJSC Kraspharma’s line of carbapenem antibiotics is Dorifarm (INN: doripenem).
View details
The well-being of patients is an unconditional priority for PJSC «Kraspharma». To achieve this goal, the Company has established and operates a Pharmacovigilance Service, whose tasks include the earliest possible detection of drug safety issues, monitoring of side effects, identifying risk factors associated with the use of the Company’s products and their quantitative assessment, as well as controlling the "risk-benefit" ratio when using pharmaceutical products.
PJSC «Kraspharma» is one of the largest Russian pharmaceutical companies, meeting the needs of healthcare institutions for essential hospital medicines. A wide range of manufactured pharmaceuticals, high product quality and availability, care for people, and dynamic development, along with the expansion of the product portfolio to meet the growing needs of healthcare – these are the key features of PJSC "Kraspharma," the only pharmaceutical enterprise in the Krasnoyarsk Krai.
